California Steamin'

A power shutdown last month at the University of California, San Francisco, sent physiology professor Mary F. Dallman into a panic. Her lab studies the effects of stress on the pituitary-adrenal axis in rats' brains, and one of her postdocs had recently begun the sort of 20-day, $10,000 experiment typically conducted by her lab. The pituitary-adrenal axis "is highly circadianly driven," Dallman explains, "and when the lights go out in the middle of the day, you're giving the circadian clock a

Written byDouglas Steinberg
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The pituitary-adrenal axis "is highly circadianly driven," Dallman explains, "and when the lights go out in the middle of the day, you're giving the circadian clock a pulse that can reset the whole animal." Plunged into darkness, the nocturnal rats began to nibble, so Dallman and two other lab members quickly set up three flashlights in the small animal room. Rats don't require much light before they begin sleeping again, and Dallman doubts that the blackout ruined the experiment.

Nevertheless, she and other California life scientists worry that the state's energy crisis might spoil its biomedical research and biotech industry for years. "You can't get by without electricity in this field," says Renee Reijo Pera, an assistant professor of obstetrics and gynecology at UCSF, who constantly runs PCR machines. Experiments and the manufacture of drugs and reagents require precision and predictability, both of which can vanish on days punctuated by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies